Eli Lilly Market Cap 2006-2018 | LLY

Eli Lilly market cap history and chart from 2006 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Eli Lilly market cap as of April 17, 2019 is $120.67B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $120.673B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $371.636B 16.85
Pfizer (PFE) United States $237.400B 13.29
Merck (MRK) United States $199.302B 17.03
Novartis AG (NVS) Switzerland $178.563B 15.19
Novo Nordisk (NVO) Denmark $118.536B 19.17
AbbVie (ABBV) United States $115.027B 9.86
Sanofi (SNY) France $103.057B 12.72
GlaxoSmithKline (GSK) United Kingdom $99.174B 13.02
AstraZeneca (AZN) United Kingdom $98.200B 11.20
Bristol-Myers Squibb (BMY) United States $74.835B 11.51